In this presentation, you have the opportunity to hear Hansa Biopharma's Global Franchise Lead for Gene Therapy, Dr. Lena Windstedt, Ph.D.

Lena Winstedt will present Hansa's gene therapy franchise as a new opportunity to solve problems around already existing antibodies against AAV-based gene therapies.

Watch the full video on our youtube channel: https://www.youtube.com/c/HCAndersenCapital

HC Andersen Capital receives payment from Hansa Biopharma through a Digital IR/Corporate Visibility agreement.